- Country: South Korea
- Summary: Eye Inflammatory and Anti-matasses Are Identified in Case of Identification and Risk Factors
- KRT Ref No: 52409403
- Deadline: 11 May 2021
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: KRW 45454545
- Notice Type: Tender
- Document Ref. No.: 20210428623-01
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Case of anti-inflammatory and pyrometric matasses Reference Number: Drug Mechanics Big Data Analysis Team -419
Assignment Budget: 50,000,000 won
Estimated price: 45,454,545 won
Bidding start: 2021/04/19 18:00:00:00
Bid Finish City: 2021/05/11 10:00:00 - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINEye Inflammatory and Anti-matasses Are Identified in Case of Identification and Risk Factors - Korea Tender
The KOREA DRUG SAFETY MANAGEMENT AGENCY, a Government sector organization in South Korea, has announced a new tender for Eye Inflammatory and Anti-matasses Are Identified in Case of Identification and Risk Factors. This tender is published on KoreaTenders under KRT Ref No: 52409403 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2021-05-11.
The estimated tender value is KRW 45454545, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
